Table 1.
Author, year | Intervention | Aim | Inclusion | Exclusion | Funding |
---|---|---|---|---|---|
Shao, 201727 | MLD | To determine if addition of MLD to the standard therapy is more effective in treatment of breast cancer related lymphedema | >10% or 2 cm or 150 ml volume difference | Non-randomized studies | None |
McNeely, 201130 | MLD | To update the evidence from RCTs concerning the benefits of conservative interventions for all cancer-related lymphedema | Lymphedema secondary to cancer | Non-randomized studies Grey literature |
Partially funded by Alberta Health Services Cancer Care |
Huang, 201328 | MLD | To evaluate the effectiveness of MLD in the prevention and treatment of breast-cancer-related lymphedema | Axillary lymph-node dissection | Only sentinel node performed | None |
Ezzo, 201529 | MLD | To assess the efficacy and safety of MLD in treating breast cancer related lymphedema | >2 cm or 200 ml or 10% excess volume | Use of non-manual form (i.e., electronic) of lymphatic drainage, use of different type of massage instead of MLD, use of MLD in both groups, altering more than the MLD component, prevention therapy | Manheimer and Ezzo partially funded by NCCAM (National Center for Complementary and Alternative Medicine) of the US National Institutes of Health |
Qiao, 202331 | MLD | To evaluate the efficacy of MLD on postmastectomy BCRL | RCT, >18 years, >150 ml increase compared with preoperatively or >2 cm or 10% excess volume | <20 patients in trial, patients with serious complications, non-English literature | None |
Liang, 202013 | MLD | To evaluate the effect of MLD on the treatment and prevention of lymphedema after breast cancer surgery | RCT, clearly defined definition of lymphedema | Grey literature | Scientific Research Foundation of Hunan Provincial Health Commission (grant no. C2017004) |
Rogan, 201632 | Compression pump and Exercise | To evaluate the effects of compression bandages, sleeves, intermittent pneumatic compression (IPC) and active exercise on the reduction of breast cancer-related lymphedema | Mentioned one of the following keywords in the title or abstract: lymphoedema, women, mastectomy, axillary dissection, or breast cancer | Non-breast cancers, lower extremity lymphoedema, impact on fatigue only, prevention therapy | NR |
Shao, 20149 | Compression pump | To determine if intermittent pneumatic pump manage lymphedema effectively | >10% or 2 cm excess volume | Non-randomization | None |
Li, 202233 | Compression pump | To compare the effects of compression therapy and routine nursing in treatment of BCRL | RCT, ≥18 years, both male and female, BRCL | Repeated publications, grey literature, incorrect or incomplete data, or the evaluation index could not be obtained, non-Chinese or English publications, animal experiments | Key Project of Scientific Research in Universities in 2020, no. KJ2020A0221. |
Rangon, 202234 | Complex physical therapy | Investigate the immediate, short-term, and long-term effects of complex physical therapy and multimodal approaches on BCRL | RCT, a minimum difference of 2 cm and 10% between the upper limbs | Non-English literature | NR |
Chen, 20198 | Laser therapy | To analyse the effectiveness and safety of laser therapy for the treatment of BCRL | RCT, breast cancer related lymphedema | Studies with inclusion of patients with medical conditions, such as current metastases, pregnancy, photosensitivity, chronic inflammatory diseases, and history of severe trauma | None |
Smoot, 20157 | Laser therapy | To examine the effectiveness of later therapy in reducing BCRL | Breast cancer related lymphedema, LLLT alone or in combination with other treatments | Primary lymphedema, case studies | Smoot partially supported by the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12, Grant Number K12HD052163 NICHD/NIH, and by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number KL2TR000143 |
Lytvyn, 202010 | Exercise and MLD | To evaluate the most common conservative lymphedema treatment strategies for treating cancer-related extremity lymphedema | RCT, ≥18 years, cancer-related extremity lymphedema, published in English | Primary lymphedema, patients at risk of lymphedema | Sadeghirad received a graduate student stipend from Mitacs Canada and received funding from PIPRA AG |
Yeung, 201835 | Exercise | To review the evidence of aquatic therapy in the management of lymphedema | Lymphedema (primary or secondary) | Non-randomization | None |
Kasawara, 20186 | Kinesio taping | To evaluate the effects of KT on lymphedema related to breast cancer | Lymphedema after mastectomy | Case reports, congenital or primary lymphedema related to types of cancer other than breast cancer, lymphedema in the lower limbs | NR |
Gatt, 20175 | Kinesio taping | To determine the effectiveness and safety of KT in the management of cancer related lymphedema | Cancer-related lymphedema | Primary lymphedema, non-randomized | Gatt supported by Malta Government Scholarship Scheme |
Hou, 20194 | Acupuncture | To explore the efficacy and safety of acupuncture treatment | Breast cancer, >2 cm excess volume | Pregnant or lactating women, patients with severe damage to the heart, liver, and kidney; abnormal bone marrow function; skin ulceration of the affected limb and infectious skin diseases; severe mental disorders, and so forth | Young Scientists Fund of the National Natural Science Foundation of China (No. 81804193), the Youth Natural foundation of the Science and Technology Department of Jiangsu Province (No. BK20161083), The Leading Talents Project from Jiangsu Provincial Administration of TCM (SLJ0206) and the peak talent project of Jiangsu Province Hospital of TCM (y2018rc05) |
Jang, 202036 | Acupuncture | To evaluate the effectiveness of acupuncture for treatment-induced symptoms in breast cancer patients | Peer-reviewed RCTs. Any stage of breast cancer, including patients with metastasis | Observational studies, cohort studies, case reports, case series, non-RCT studies, animal, and experimental studies | Traditional Korean Medicine R&D Program funded by the Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI) (HB16C0072) |